1. <cite id="gscps"><track id="gscps"></track></cite>
      <samp id="gscps"><center id="gscps"></center></samp>

      亚洲人妻一区二区精品,67194熟妇在线观看线路,夜夜爽一区二区三区精品,日韩中文字幕亚洲精品,国产98在线 | 欧美,国产无码十八禁,精品无码国产自产野外拍在线,日韩午夜精品一区二区三区无码Av
      咨詢熱線

      15000266580

      當前位置:首頁 >產品中心>細胞庫>人腫瘤細胞、癌細胞>CRL-2557Panc 05.04 人胰腺癌細胞

      Panc 05.04 人胰腺癌細胞

      簡要描述:CRL-2557 Panc 05.04 人胰腺癌細胞,
      原代細胞|細胞系|細胞株|菌種;細胞庫管理規范,
      提供的細胞株背景清楚,提供參考文獻和培養條件!

      • 產品型號:CRL-2557
      • 廠商性質:生產廠家
      • 更新時間:2025-11-12
      • 訪  問  量:2378

      產品分類

      Product Category

      詳細介紹

      CRL-2557 Panc 05.04 人胰腺癌細胞

      ATCC® Number: CRL-2557™ Price: $417.00

      Designations: Panc 05.04

      Depositors: EM Jaffee

      Biosafety Level: 1

      Shipped: frozen

      Medium & Serum: See Propagation

      Growth Properties: adherent

      Organism: Homo sapiens (human)

      Morphology: epithelial

      Source: Organ: pancreas

      Disease: adenocarcinoma

      Cellular Products: cytokeratins 7 and 18 [50655]

      Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.


      CRL-2557 Panc 05.04 人胰腺癌細胞

      Isolation: Isolation date: May 5, 1995

      Tumorigenic: Yes

      Oncogene: K-ras +

      Antigen Expression: MHC class I +; MHC class II - [50655]

      Blood type B; Rh+

      Age: 77 years adult

      Gender: female

      Ethnicity: White

      Comments: Panc 05.04 is a pancreatic adenocarcinoma epithelial cell line derived, in 1995, from a primary tumor removed from the head-of-the-pancreas of a female with pancreatic adenocarcinoma.

      The cell line exhibits a K-ras oncogene mutation at codon 12 where a GGT --> GAT mutation resulted in substitution of aspartic acid for glycine. [50655]

      The cells have a reported plating efficiency of 100%. [50655]

      Propagation: ATCC complete growth medium: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate and supplemented with 20 Units/ml human recombinant insulin, 85%; fetal bovine serum, 15%

      Atmosphere: air, 95%; carbon dioxide (CO2), 5%

      Temperature: 37.0°C

      Subculturing: Protocol:

      1.Remove and discard culture medium.

      2.Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.

      3.Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).

      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

      4.Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.

      5.To remove trypsin-EDTA solution, transfer cell suspension to centrifuge tube and spin at approximay 125 xg for 5 to 10 minutes.Discard supernatant and resuspend cells in fresh growth medium. Add appropriate aliquots of cell suspension to new culture vessels.

      6.Incubate cultures at 37°C.

      Subc*tion Ratio: A subc*tion ratio of 1:3 to 1:5 is recommended

      Medium Renewal: Add media once per week. Fluid change one to two times per week.

      Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO

      Storage temperature: liquid nitrogen vapor phase

      Doubling Time: 46 hrs

      Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001

      recommended serum:ATCC 30-2020

      References: 50655: Jaffee EM, et al. Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J. Sci. Am. 4: 194-203, 1998. PubMed: 9612602

      CRL-2557


















      產品咨詢

      留言框

      • 產品:

      • 您的單位:

      • 您的姓名:

      • 聯系電話:

      • 常用郵箱:

      • 省份:

      • 詳細地址:

      • 補充說明:

      • 驗證碼:

        請輸入計算結果(填寫阿拉伯數字),如:三加四=7
      聯系方式

      郵箱:xiangfbio@163.com

      地址:上海市虹口區四平路710號7層

      咨詢熱線

      400-821-8510

      (周一至周日9:00- 19:00)

      在線咨詢
      • 掃一掃 微信咨詢

      Copyright©2025 上海復祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
      技術支持:化工儀器網    管理登陸
      主站蜘蛛池模板: 无码人妻久久一区二区三区免费丨| 亚洲精品美女一区二区| 精品国产一区二区av片| 无码专区人妻系列日韩精品少妇| 美女精品黄色淫秽片网站| 亚洲精品国产一二三无码AV| 18pao成人国产永久视频| 亚洲精品日产AⅤ| 欧美裸体bbwbbwbbw| 欧美三级不卡在线观看视频| 亚洲va在线va天堂xx xx| 久久国产精品99精品国产| 亚洲а∨天堂2019在线无码 | 欧美成人aa免费观看| 狠狠v日韩v欧美v| 亚洲成av人片在线观看无码不卡| 色噜噜在线视频免费观看| 亚洲最大的熟女水蜜桃AV网站| 久久精品一区二区东京热| 亚洲精品欧美综合四区| 女同互玩中文字幕久久| 浪潮AV激情高潮国产精品| 亚洲天堂网中文在线资源| 国产在线啪| 国产av无码专区亚汌a√| 国产成人精品免费久久久久| 亚洲精品岛国片在线观看| 免费一级A片久久精品| 亚洲综合视频一区二区三区 | 国产国产精品人体在线视| 偷窥日本少妇撒尿chinese| 两个人在线看视频| 亚洲av综合av一区| 韩国电影伦理片| 无码国产精成人午夜视频一区二区| 永久免费无码成人网站| 欧美天天拍在线视频| 国产精品熟女乱色一区二区| 少妇又色又紧又爽又刺激视频| 久久久亚洲色| 日本高清一区二区视频在线观看|